Filing Flows

Filing Flows › Fennec Pharmaceuticals (FENC) › Who owns the stock

Who owns Fennec Pharmaceuticals (FENC) stock

100 funds reported Fennec Pharmaceuticals (FENC) shares in their latest 13F filings, worth $189M in all. The largest holder is Rosalind Advisors ($34.3M). Last quarter 58 funds added to their stakes and 25 cut them.

Largest holders of FENC (13F)Largest holders of FENC (13F)Rosalind Advisors$34.3MAigh Capital Management LLC$26.6MSolas Capital Management, LLC$20.3MBlackRock$18.6MSonic GP LLC$15.2MVanguard Capital Management LLC$9.0MVanguard Group$8.2MProspect Capital Advisors, LLC$5.4MState Street$4.6MGeode Capital Management, LLC$4.3M

Largest holders (13F)

FundSharesValueChangeQuarter
Rosalind Advisors3,188,001$34.3Mincrease2026-06-30
Aigh Capital Management LLC2,499,421$26.6Mincrease2026-09-30
Solas Capital Management, LLC1,889,366$20.3Mdecrease2026-06-30
BlackRock1,727,069$18.6Mincrease2026-06-30
Sonic GP LLC2,407,357$15.2Munchanged2024-12-31
Vanguard Capital Management LLC839,306$9.0Mdecrease2026-06-30
Vanguard Group1,067,651$8.2Mincrease2025-12-31
Prospect Capital Advisors, LLC497,800$5.4Mnew2026-06-30
State Street426,004$4.6Mincrease2026-06-30
Geode Capital Management, LLC402,566$4.3Mincrease2026-06-30
Essex Investment Management Co LLC318,771$3.4Mnew2026-09-30
Jane Street Group, LLC233,877$2.5Mnew2026-06-30
Potomac Capital Management224,400$2.4Munchanged2026-06-30
Morgan Stanley221,920$2.4Mincrease2026-06-30
Vanguard Portfolio Management LLC199,998$2.1Mincrease2026-06-30

Fennec Pharmaceuticals' latest quarter

Fennec Pharmaceuticals, Q2 2026: revenue $17.9M (+85% year over year), operating margin 9.7%, net earnings $2.0M, operating cash flow $50K. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most FENC stock?

By the latest 13F filings: Rosalind Advisors ($34.3M); Aigh Capital Management LLC ($26.6M); Solas Capital Management, LLC ($20.3M); BlackRock ($18.6M); Sonic GP LLC ($15.2M).

What is the short interest in FENC?

487,514 shares were sold short at the 2026-10-15 settlement, -5.02% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.